N-acetylglucosamine
Tier C — Watch / tradeN-acetylglucosamine
Targets：ELANE
Indications (approved)：Crohn's disease, Solid tumour, Hepatocellular carcinoma, 严重急性营养不良, Irritable bowel syndrome
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| NACE-001 | 14131-63-6 | (2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol hydrochloride |
| NACE-002 | 14257-69-3 | (2R,3R,4R,5S,6R)-3-amino-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol |
Frequently asked questions
What are the approved indications of N-acetylglucosamine?
Approved indications include: Crohn's disease, Solid tumour, Hepatocellular carcinoma, 严重急性营养不良, Irritable bowel syndrome.
When does the N-acetylglucosamine patent expire?
No public expiry year is available for N-acetylglucosamine yet; this page updates once verified.
How many synthesis routes are recorded for N-acetylglucosamine?
1 synthesis routes are recorded; the shortest is 2 steps with 42.6 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy N-acetylglucosamine intermediates?
All intermediates in N-acetylglucosamine routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.
How do I get a quote for N-acetylglucosamine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-07